ConductScience.org, home

Trial · NCT02114359

Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer

NCT02114359, Phase 3, Completed, Seoul National University Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer. Trials, record NCT02114359. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02114359

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
NCT number
NCT02114359
Status
Completed
Phases
Phase 3
Enrollment
111 participants, actual
Lead sponsor
Seoul National University Hospital
Conditions
Gastric Cancer
Interventions
Capecitabine/cisplatin, S-1/cisplatin, Capecitabine/oxaliplatin, 5-fluorouracil/oxaliplatin, Capecitabine, S-1, 5-fluorouracil
First posted
2014-04-15
Last updated
2020-10-23

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primarycomparison of overall survivalupto 3years
Secondarycomparison of progression-free survivalupto 2years
Secondarycomparison of response rateupto 2years
Secondarycomparison of adverse eventsupto 2yrs
Secondarycomparison of quality of lifeupto 2years
Othercomprehensive geriatric assessmentbaseline
The investigators are going to evaluate that comprehensive geriatric assessment tested at baseline can predict the toxicity and compliance to treatment, survival of patients. Comprehensive geriatric assessment will not necessarily be tested in all subjects, but instead, screening tool (KG-7 (Korean screening tool for the elderly)) will be tested in all subjects.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers9

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
1801881BACKGROUNDPubMed
8508349BACKGROUNDPubMed
10765119BACKGROUNDPubMed
10894863BACKGROUNDPubMed
12506170BACKGROUNDPubMed
18172173BACKGROUNDPubMed
18282805BACKGROUNDPubMed
18665164BACKGROUNDPubMed
19153121BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02114359

GET https://conductscience.org/api/trials/v1/NCT02114359/registered